Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
Astellas Institute for Regenerative Medicine
open-in-new
<p>Astellas Institute for Regenerative Medicine is a subsidiary of <a href="/facts/Astellas_Pharma/6UBC1GWI">Astellas Pharma</a> located in <a href="/facts/Marlborough%2c_Massachusetts/3Ukm1b1H">Marlborough, Massachusetts</a>, US, developing <a href="/facts/Stem_cell_therapy/dXme5FTo">stem cell therapies</a> with a focus on diseases that cause <a href="/facts/Visual_impairment/sFuqKj3n">blindness</a>. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated (ACT), which was renamed to Ocata Therapeutics in November 2014. In February 2016 Ocata was acquired by Astellas for $379 million USD. </p><p> </p>